Global Expansion, GanedenBC30`s 18th published study, and two partners as finalists in the 2014 SupplySide CPG Editor`s Choice Awards is news worth celebrating.
CLEVELAND, OH (September 30, 2014) - Ganeden Biotech is heading to SupplySide West 2014 with much to celebrate. The company is proud to announce their international regulatory push, GanedenBC30`s 18th published study, the first ever probiotic Food Chemical Codex Monograph, and two probiotic partners; The Cookie Department and KeVita are finalists in the SupplySide CPG Editor`s Choice Awards.
GanedenBC30 has received regulatory approvals in over sixty countries throughout the world; most recently GanedenBC30 has been approved in Mexico, Japan, India, Taiwan and the Philippines; with many more being announced as 2014 comes to a close. The global footprint of GanedeBC30 continues to grow, granting endless opportunities for innovative probiotic food and beverage applications all over the world.
The 18th published study on GanedenBC30 has just been completed. This study demonstrated that GanedenBC30 supports both digestive and immune health in HIV subjects. The study also provided additional evidence that even in an immune-compromised subject group, there is an absence of safety concerns when consuming GanedenBC30 on a daily basis.
The first ever probiotic monograph is now published in the Food Chemical Codex (FCC) from the U.S. Pharmacopeial Convention ("USP"). The monograph is specific to the strain Bacillus coagulans GBI-30, 6086 (GanedenBC30) and provides strain specific standards for testing the identity, concentration and purity of the probiotic.
Informa Exhibitions has named two Ganeden Biotech partner products as finalists in the 2014 SupplySide CPG Editor`s Choice Awards. Designed to recognize innovation and market significance, five 2014 consumer packaged goods (CPG) products were selected by the SupplySide editorial team in 20 different categories. One winner in each category will be announced at SupplySide West 2014 during the SupplySide CPG Editor`s Choice Awards Reception, set for Wednesday, October 8 at the Mandalay Bay Resort in Las Vegas, Nevada.
Both formulated with the probiotic GanedenBC30; The Cookie Department`s probiotic Cherry Bomb cookie is a finalist in the Snacks category and KeVita`s Blueberry Cherry, Tangerine, and Hibiscus Berry probiotic sparkling drink were named to the short list in the Digestive Health category.
"As a start-up, creating a first-to-market brand is always a challenge", says Pam Marcus, CEO of The Cookie Department. "The Cookie Department is special because we put science-backed, functional ingredients into cookies that taste really good; that is why it was natural for us to partner with Ganeden Biotech for our probiotic Cherry Bomb cookie. We are thrilled to be recognized as a finalist by SupplySide West for having unique and innovative products."
"It is exciting to be able to go to such a globally respected show such as SupplySide West with so many exciting achievements", says Mike Bush, Senior Vice President of Ganeden Biotech. "We are especially happy for KeVita and The Cookie Department on being finalists in the SupplySide CPG Editor`s Choice Awards; their desire to bring innovative, one of its kind probiotic products to the market is why we are honored to have them as partners." Added Bush; "we wish both companies the best of luck."
Visit Ganeden Biotech at SupplySide West booth # 15094 to learn more about all of this exciting news and the many opportunities available to innovate and profit with probiotics.
About Ganeden Biotech
Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, highly stable probiotic ingredient. Ganeden`s newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden Biotech and licensing opportunities visit GanedenBiotech.com.
Introducing GanedenBC30® (Bacillus coagulans GBI-30, 6086), Ganeden Biotech`s patented probiotic ingredient that can be found in more than 100 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains, GanedenBC30 is a spore-forming organism which makes it highly stable and allows it remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 18 published studies showing digestive and immune support and GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any product that experiences high or low temperature, pressure or environmental extremes including all hot or refrigerated beverages! For more information, please visit GanedenBiotech.com or GanedenBC30.com.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ganeden Biotech via GlobeNewswire